Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TRAVOPROST vs TREPROSTINIL DIOLAMINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TRAVOPROST vs TREPROSTINIL DIOLAMINE: Safety Overview

Metric TRAVOPROST TREPROSTINIL DIOLAMINE
Total FAERS Reports 6,455 250
Deaths Reported 145 40
Death Rate 2.2% 16.0%
Hospitalizations 164 136
Average Patient Age 71.6 yrs 55.7 yrs
% Female Patients 63.0% 79.2%
FDA Approval Date Dec 13, 2023 Dec 20, 2013
Manufacturer Sagent Pharmaceuticals N/A
Route OPHTHALMIC N/A
Marketing Status Discontinued Prescription